Articles tagged with Glia
Recent discoveries have shed light on gene expression control in tumor growth, revealing the critical role of epigenetic marks and genomic imprinting. The findings have significant implications for cancer treatment, as they suggest that disrupting the tumor's access to neural signaling may halt its growth.
A new study reveals that astrocytes regulate inhibitory signaling in the cerebellum during development, enabling the emergence of flexible and precise motor coordination. In contrast, younger animals rely on neuron-derived tonic inhibition, which is replaced by astrocyte-derived tonic inhibition in late adolescence.
A new study reveals that astrocytes actively participate in motor-learning circuit rewiring by eliminating synapses in the striatum. The research identifies MEGF10 as a key molecular mediator of this process, which is regulated by dopamine signaling and neural activity.
Cancer cells tap into the nervous system's power grid by forming synaptic contacts with nerve cells, promoting tumor growth and spread. Venkataramani's research aims to repurpose the drug perampanel for glioblastoma treatment and develop gene therapy approaches to disconnect tumors from the nervous system.
Scientists found that blocking microglia prevents infant forgetting and improves memory in mice, suggesting a role for microglia in memory formation. Microglia inhibition also enhances engram cell activation, providing a functional explanation for enhanced memory recall.
Research highlights glial cells as dynamic regulators of brain health, playing both protective and harmful roles in neural function. Promising therapeutic targets include oligodendrocyte dysfunction, mitochondrial transfer, and extracellular vesicle engineering.
Scientists at Lund University have created a new method to directly reprogram glial cells into parvalbumin neurons, which can help regulate brain activity and potentially treat disorders such as schizophrenia and epilepsy. The breakthrough could lead to therapies that replace lost or damaged brain cells in the future.
Researchers discovered that female brain immune cells called microglia express more interferon-related genes when responding to amyloid-β plaques, causing more harm to neuronal connections. This finding suggests a potential sex-specific treatment approach for Alzheimer's disease.
Scientists at Salk Institute find protein CCN1, secreted by astrocytes, maintains stable neural circuits in adult brains. The discovery could lead to new therapeutics for brain injury and stroke.
Astrocytic glutamine synthetase plays a key role in regulating glutamate signaling, contributing to nicotine-induced brain changes and locomotor sensitization. A custom-designed peptide inhibits this process, demonstrating the importance of astrocyte communication in nicotine addiction.
Researchers have identified a new immune process that clears toxic amyloid plaques and delays cognitive decline in Alzheimer's disease. The 'Fc fragment' of the monoclonal antibody Lecanemab activates microglia, the brain's immune cells, to remove plaques more efficiently.
Researchers identify a rare gene mutation that appears to protect the brain's immune cells from damage caused by Alzheimer's disease. The study reveals how this mutation can confer resilience on the brain, potentially leading to new therapeutic approaches.
Researchers found that a protein involved in ATP release, connexin 43, plays a key role in depressive- and anxiety-like behaviors. Restoring connexin 43 in the hippocampus improved behavioral outcomes and boosted ATP levels in stressed mice.
A new study reveals that astrocytes, a type of glial cell, are responsible for stabilizing memories through repeated engagement. The researchers found that Fos activity in astrocytes only occurs during recall, and that these cells can be activated to produce stable memories.
Research reveals that ovarian aging is not just about egg quality, but also the surrounding cells and tissues. The study found that eggs cluster in pockets surrounded by egg-free zones, which decline in density with age, influencing egg lifespan and maturation.
Researchers found that an astrocytic 'brake' mechanism, fueled by the neurotransmitter GABA, blocks spinal cord repair after injury. Inhibiting this pathway with the MAOB inhibitor KDS2010 enables recovery of spinal cord function in animal models.
A USF-led Nature study identifies how a genetic variant disrupts microglia function, increasing Alzheimer's disease risk. The PICALM gene defect impairs waste-processing organelles in microglia, causing harmful lipid droplets to accumulate and weaken their ability to clear debris.
Research reveals neuroglia play active role in brain function, driving disease progression through atrophy and functional decline. Therapeutic strategies targeting neuroglial signaling may prevent damage following brain injury or protect against neurodegenerative processes.
Researchers have discovered that microglia, the brain's immune cells, play a key role in how the brain adapts during adolescence. This understanding may transform how neurodevelopmental disorders are treated during this window and possibly into adulthood. The study also found that microglial contact with axons increases dopaminergic ci...
Researchers have reimagined hemoglobin as an antioxidant protein in the brain, where it breaks down harmful reactive oxygen species. A new compound, KDS12025, selectively enhances this natural defense mechanism to protect against ALS, Parkinson's, Alzheimer's, and autoimmune disorders.
Researchers at the Institute for Basic Science have discovered that excessive GABA produced by astrocytes impairs fear extinction in PTSD. A new brain-permeable drug called KDS2010 has reversed PTSD-like symptoms in mice, providing a promising therapeutic approach.
Laminin-411 protein and its derived peptide A4G47 exhibit pro-myelinating activity in oligodendrocytes, promoting myelin sheath formation. This discovery advances understanding of myelin sheath formation and potential applications for treating demyelinating diseases.
In a breakthrough study, researchers at the University of Rochester Medical Center found that microglia cells respond differently than neutrophils to photoreceptor damage in the retina. This discovery has high implications for treating vision loss caused by photoreceptor cell damage.
Researchers discovered a two-step mechanism where inhibitory neurons release nitric oxide to rapidly dilate blood vessels, followed by slower, localized vasodilation via astrocyte activation. This breakthrough sheds light on how neural signals are translated into blood volume changes in brain imaging.
A combination of two approved cancer medications may slow or reverse Alzheimer's symptoms by reversing gene expression changes in neurons and brain cells. Researchers analyzed public data from deceased donors and found a link between these drugs and reduced risk of developing the disease.
A recent study using machine learning and computational modeling reveals that astrocytes play a more active role in brain function than previously thought. Astrocytes subtly modulate communication between neurons during synchronous brain activity, influencing network coordination and stability.
Researchers at Florida Atlantic University have secured two key grants to investigate targeting the MBLAC1 gene as a new approach to treat glioblastoma, a very aggressive and fast-growing type of brain cancer. The project aims to advance innovative projects that could make a meaningful impact on cancer therapy.
A UC Riverside study found that Toxoplasma gondii can significantly disrupt brain function by interfering with communication between brain cells. Infected neurons release fewer extracellular vesicles, which can lead to seizures, neural damage, or altered brain connectivity.
Astrocytes, once thought to be supporting cells, are active players in neuromodulation, controlling neuronal activity and behavior. The discovery of a biochemical circuit involving ATP and adenosine reveals a slower time scale for modulation compared to neural circuits.
Researchers found that astrocytes transmit signals, revealing new ways the brain processes information. The study provides direct evidence for the real-time action of astrocytes in live brains of fruit flies, suggesting their role in mediating neurophysiology and behavior.
Researchers at Linköping University developed a miniaturized iontronic micropipette to precisely modulate neuronal and astrocytic activity. The study revealed dynamic dynamics between cells, highlighting the importance of chemical signaling in brain function.
Researchers have found that promoting glucose metabolism in glial cells can relieve inflammation and photoreceptor degeneration in Alzheimer's patients. This discovery presents an exciting new therapeutic target for treating neurodegenerative conditions like Parkinson's.
A USC Stem Cell mouse study has identified shared genes involved in regenerating cells in the ear and eye, which could lead to new treatments for hearing and vision loss. The researchers discovered that inhibiting a specific protein, p27Kip1, can encourage regeneration in both organs.
A review article reveals CD2AP's crucial role in amyloid metabolism, tau pathology, synaptic function, and neuroinflammation in Alzheimer's disease. CD2AP deficiency accelerates plaque formation, while its loss in neurons leads to reduced spine density and impaired synaptic plasticity.
Studies have consistently shown that 40Hz gamma stimulation can improve cognitive function and reduce Alzheimer's pathology in mice. In human clinical trials, participants exposed to 40Hz light and sound experienced significant slowing of brain atrophy and improvements on some cognitive measures compared to untreated controls.
Researchers at Johannes Gutenberg University Mainz have discovered that histone deacetylase 8 (HDCA8) inhibits the conversion of Schwann cells into their repair phenotype, slowing down peripheral nervous system recovery. Removing HDAC8 accelerates regeneration and restores sensory function.
A fungal infection has been shown to trigger a fruit fly's own immune system to destroy brain cells leading to signs of neurodegeneration. The fungus makes the fly's innate immune system release Sarm, which suppresses the immune response and kills brain cells.
Researchers found that glial cells accumulate excess extracellular matrix proteins and alter gene expression when detecting damaged cilia. This discovery may have implications for treating diseases caused by defective cilia, such as polycystic kidney disease.
Researchers have found that microglia function differently in adult male versus female mice when given an enzyme inhibitor, with potential broad implications for how neurological diseases are studied. This discovery highlights the necessity of gender-specific research and may lead to new disease-modifying therapies targeting microglia.
Researchers developed a new tool to measure biological aging in individual cell types, providing insights into diseases like Alzheimer's and liver pathologies. The study found that certain brain cells and liver cells show signs of accelerated aging, making it a better tool for detecting diseases.
Professor Robert Fledrich has been awarded an ERC Consolidator Grant for his research on the regeneration of peripheral nerves. His team aims to investigate the conditions required for successful nerve regeneration, focusing on glial cells' metabolic dynamics and communication pathways.
Researchers found that specific enzymes in neurons mediate the toxicity of diets rich in palm oil, leading to mitochondrial damage and neurodegeneration. Inactivating these enzymes provides neuroprotection, suggesting a potential pathway for slowing diet-induced symptom severity in MS patients.
A new study from the CUNY Graduate Center uncovers key mechanisms responsible for the transformation of adult progenitor cells into brain tumors. Researchers found that a specific combination of genetic mutations and growth factor overproduction drives this transformation, highlighting the importance of epigenetic changes in glioma dev...
A study by Baylor College of Medicine researchers reveals that Tau protein mitigates neuronal damage caused by reactive oxygen species and promotes healthy aging. The findings support a new neuroprotective role for Tau against the toxicity associated with ROS.
Researchers have created the largest collection of patient stem cell models of multiple sclerosis, identifying unique ways in which glia contribute to the disease. The study suggests that glial cells from MS patients have intrinsic hallmarks of disease, independent of immune system influences.
Researchers at Rice University have developed a nanosized sensor that records the electrical activity of spinal neurons in action. The sensor, called spinalNET, can track individual neurons over multiple days, providing valuable insights into the mechanisms controlling movement and sensation in the spinal cord.
Researchers have identified a cellular mechanism that detects when the brain needs an extra energy boost to support its activity. This discovery could lead to new therapies for maintaining brain health and longevity by targeting impaired brain energy metabolism, a process accelerated in ageing and neurodegenerative diseases.
Senescent cells, 'zombie-like' cells that resist death, accumulate in the brain with age, contributing to cognitive declines and frailty. Researchers identified a specific pathway linked to senescence in fruit fly brains, potentially paving the way for therapies to delay age-associated pathologies.
Researchers at the University of Rochester Medical Center found that ketones can rescue impaired neuronal function in the hippocampal network. This study suggests a potential therapeutic approach for preventing or delaying neurodegenerative diseases like Alzheimer's.
Researchers discover a new mechanism of neural plasticity underlying learning and memory processes, highlighting the crucial role of chondroitin sulfates in brain function. The study provides insights into how these molecules contribute to synaptic modifications and spatial memory.
Neuroscientists at Fred Hutchinson Cancer Center have found that glial cells use different molecules to communicate with different neurons, enabling distinct 'conversations' with each neuron. This clustering of molecules ensures that the glial cell can influence how neurons respond to environmental cues like temperature and smell.
Researchers at Salk Institute have created a novel organoid model of the human brain that includes mature, functional astrocytes. This allows for the study of inflammation and stress in aging and diseases like Alzheimer's with greater clarity, revealing a relationship between astrocyte dysfunction and inflammation.
A new framework has been established for standardized imaging of diffuse gliomas using amino acid PET, enabling the evaluation of treatment success and improving therapies. The RANO group has developed criteria that enable reliable imaging of tumor activity and extent.
Researchers at the University of Rochester Medical Center find that microglia can trigger cognitive deficits after radiation exposure, potentially targeting them for therapy development. Mice studies showed that blocking a specific pathway in microglia prevented cognitive decline, offering hope for improving patients' quality of life.
Researchers discovered that microglia regulate neuronal activity in a brain region-specific manner, playing a key role in how anesthesia works. Microglia depletion delayed induction and led to early emergence of anesthesia.
Researchers at Helmholtz Munich have identified a new source of stem cells in the brains of patients with brain injuries, which could lead to improved treatments for neurological disorders. The discovery involves specific astrocyte cells that exhibit properties of neural stem cells and can be regulated by a protein called Galectin 3.
Researchers at Tohoku University found that Bergmann glial cells in the cerebellar vermis regulate the volume of aggression in mice. The study suggests that adjusting glial activity in the cerebellum could lead to therapeutic strategies for managing anger and aggression.
Researchers have successfully converted human retinal cells, specifically Muller glia, into neurons in a lab setting using an artificial fish-like genetic program. This breakthrough could potentially serve as a new source of neurons to treat vision loss caused by disease or trauma.
Researchers at Michigan State University found that glial cells in the gut can sensitize nearby neurons, causing them to send pain signals more easily during inflammation. This discovery could help develop new therapies to alleviate visceral pain by counteracting the glia's sensitizing efforts.
Researchers developed prodrugs that temporarily incorporate thyroxine or a thyroxine-like molecule to enhance brain drug delivery. These prodrugs were efficiently delivered into glial cells via the OATP1C1 transporter, targeting chronic inflammation in the brain.